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Neonatal ureteral obstruction alters expression of renal sodium
transporters and aquaporin water channels.
Background. Congenital urinary tract obstruction is a com-
mon cause of renal insufficiency in the neonate and during in-
fancy. Recently, we demonstrated that ureteral obstruction in
adult rats is associated with reduction in the abundance of re-
nal aquaporins (AQPs) and renal sodium transporters, which
paralleled an impaired urinary concentrating capacity.
Methods. In the present study, renal handling of sodium and
water, together with the expression of renal aquaporins and ma-
jor renal sodium transporters, was examined in rats with neona-
tally induced partial unilateral ureteral obstruction (PUUO)
within the first 48 hours of life to clarify the molecular mech-
anisms involved in the tubular functional defects in response
to congenital obstruction. Rats were then followed for 12 or
24 weeks.
Results. Neonatal PUUO caused a progressive reduction in
single kidney glomerular filtration rate (SKGFR) on the ob-
structed side to 43% of controls at 12 weeks (115 ± 28 vs. 267 ±
36 lL/min/100g bw, P < 0.05), and 31% of controls at 24 weeks
(106 ± 24 vs. 343 ± 41 lL/min/100g bw, P < 0.05). Na-K-ATPase
abundance was decreased in the obstructed kidney compared
with the nonobstructed kidney at 24 weeks (79 ± 6%, P < 0.05),
and the abundance of bumetanide-sensitive Na-K-2Cl cotrans-
porter (BSC-1) located to the medullary thick ascending limb
(mTAL) of the obstructed kidney was significantly reduced both
at 12 weeks (42 ± 10%, P < 0.05) and 24 weeks (50 ± 10%,
P < 0.05). Immunohistochemistry confirmed down-regulation
of BSC-1 both at 12 and 24 weeks after onset of obstruction.
Consistent with this, sodium excretion from the obstructed kid-
ney was increased at 12 weeks (0.13 ± 0.03 vs. 0.04 ± 0.01
lmol/min/100g bw, P < 0.05), and persisted 24 weeks after onset
of PUUO (0.15 ± 0.02 vs. 0.06 ± 0.01 lmol/min/100g bw, P <
Key words: obstructive nephropathy, kidney tubules, urinary concen-
trating capacity, sodium excretion, aquaporin, sodium transporter, rat.
Received for publication January 2, 2003
and in revised form August 6, 2003, and December 25, 2003
Accepted for publication January 27, 2004
C© 2004 by the International Society of Nephrology
0.05). AQP2 abundance in the collecting duct was also reduced
both at 12 weeks (68 ± 5%, P < 0.05) and at 24 weeks (69 ± 13%,
P < 0.05). Consistent with this, solute-free water reabsorption
was decreased in the obstructed kidney at 12 weeks (0.61 ±
0.42 vs. 1.97 ± 0.63 lL/min/100g bw, P < 0.05) and remained
decreased after 24 weeks of PUUO (0.42 ± 0.04 vs. 1.56 ±
0.39 lL/min/100g bw, P < 0.05).
Conclusion. Major sodium transporters and aquaporins in
the obstructed kidney are down-regulated in response to neona-
tally induced PUUO, which indicates that these transporters
may play a crucial role for the persistent reduction in renal han-
dling of sodium and water in response to PUUO.
Congenital urinary tract obstruction is a frequent man-
ifestation in neonates with malformations of the urinary
tract, and it is characterized by profound impairment
of kidney function involving both glomerular filtration
rate (GFR) and tubular handling of water and solutes
[1]. Characteristically, urinary tract obstruction increases
impedance in the renal pelvis and ureter, which causes
an increase in the renal pelvic pressure. Subsequently,
a reduction of renal blood flow (RBF) and GFR is in-
duced by active vasoconstrictor mechanisms within the
kidney vasculature due to an increased renal abundance
of vasoconstrictive compounds [2, 3]. In parallel, tubu-
lar sodium reabsorption and urinary concentration be-
come impaired [1]. Previous studies have demonstrated
the segmental localization of sodium transporters along
the nephron [4–6]. The key sodium transporters respon-
sible for transport of NaCl across the apical membrane
are type 3 Na/H exchanger (NHE3) in the proximale
tubule [5] and the apical bumetanide-sensitive Na-K-
2Cl cotransporter (BSC-1 or NKCC2) in the medullary
thick ascending limb (mTAL) [4]. In the basolateral mem-
brane, sodium is transported actively out of the cell by the
Na-K-ATPase [6]. Previous studies have demonstrated
that urinary tract obstruction is associated with a reduced
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Na-K-ATPase activity [7, 8] and abundance of Na-K-2Cl
cotransporter measured by a reduction in the saturable
[3H] bumetanide binding to the Na-K-2Cl cotransporter
[7]. Recently, we found that acute unilateral ureteral oc-
clusion (UUO) for 24 hours in adult rats is associated
with a reduced abundance of several major renal sodium
transporters demonstrating that transporters located to
all segments of the nephron and collecting duct may be af-
fected by acute urinary tract occlusion [9]. Thus, it is spec-
ulated that impaired sodium reabsorption in response to
neonatally induced partial unilateral ureteral obstruction
(PUUO) may be associated with altered expression of
these major renal sodium transporters.
It was previously demonstrated that release of obstruc-
tion in rats with 24 hours of bilateral ureteral obstruction
(BUO) is associated with a postobstructive diuresis [1].
Importantly, long-term PUUO in neonatal rats was asso-
ciated with an increased water excretion when examined
at 1 year of age, suggesting a persisting defect in urine
concentrating capacity [10]. Recently, we demonstrated
that ureteral obstruction (BUO and UUO) is associated
with a decreased abundance of aquaporin1 (AQP1), -2
(AQP2), and -3 (AQP3) [11, 12]. Aquaporins are a fam-
ily of membrane water channels that mediate rapid water
transport across the cell membrane [13]. Recent stud-
ies have identified the role of aquaporins in both short-
term and long-term regulation of body water balance
and have elucidated their critical roles in multiple wa-
ter balance disorders [13, 14]. AQP1 is highly abundant
in the proximal tubule and descending thin limb, and the
critical role of AQP1 in urinary concentration was con-
firmed in transgenic knockout mice lacking AQP1 [15].
At least three aquaporins (AQP2, AQP3, and AQP4)
are expressed in kidney collecting duct principal cells.
AQP2 is the apical water channel of collecting duct prin-
cipal cells, and is the chief target for vasopressin regula-
tion of collecting duct water permeability [16]. A series
of studies have shown that altered expression and api-
cal targeting of AQP2 play a significant role in multiple
hereditary and acquired water balance disorders (recent
review [17]). Water transport across the basolateral
plasma membrane of collecting duct principal cells is me-
diated by AQP3 [18] and AQP4 [19]. Consistent with
this, transgenic mice lacking AQP3 are markedly polyuric
[20], and inner medullary collecting ducts (IMCD) from
AQP4-deficient mice demonstrated a significant reduc-
tion in vasopressin-induced water permeability [21].
Thus, we hypothesize that changes in the abundance of
renal aquaporins may play an important role for the uri-
nary concentrating defect in PUUO.
In the present study, we therefore aimed to examine
whether long-term PUUO induced at birth affects the
abundance of key renal sodium transporters and aqua-
porins; and whether such changes are associated with im-
paired renal handling of sodium and water.
METHODS
Animal preparation
Experiments were performed using male Wistar rats.
Rats were subjected to PUUO or sham operation within
the first 48 hours of life. PUUO was created using a mod-
ification of the Ulm and Miller’s technique, which results
in development of severe hydronephrosis [22–24]. Briefly,
the newborn rats were anesthetized with ether and placed
on a heated table. The left ureter was exposed through a
midline incision. Embedding two thirds of the left ureter
in a muscle tunnel of the underlying psoas muscle created
PUUO. SHAM group was prepared by laparotomy and
mobilization of the left ureter. After surgery, rats were
kept in an incubator at 30◦C until totally awake, and then
returned to regular animal units with their mother. Af-
ter 4 weeks, the rats were separated from their mother
and housed 2 per cage. During the experiments the rats
were maintained at controlled temperature (22–24◦C)
and moisture (60%) with a 12-hour artificial light-dark
cycle. The rats were fed a standard rodent diet and tap
water.
The rats were divided into 4 groups: (1) PUUO–12
weeks; (2) SHAM–12 weeks; (3) PUUO–24 weeks; and
(4) SHAM–24 weeks. GFR, urinary sodium excretion,
and solute-free water reabsorption were examined at 12
or 24 weeks of age, respectively, and then the rats were
terminated. The harvested kidneys were rapidly frozen
in the liquid nitrogen and kept at −80◦C until assayed or
rapidly put into formalin for immunohistochemistry.
Catheterizations and renal clearance of 51Cr-EDTA
GFR was measured using renal clearance of
chromium-51 ethylenediaminetetraacetic acid (51Cr-
EDTA) at 12 or 24 weeks after the onset of PUUO.
Seven days before the clearance studies, the left femoral
artery and vein were catheterized under intraperitoneal
anesthesia with Pentothal (50 mg/kg bw; Abbott Scandi-
navia, Solna, Sweden). The arterial and venous catheters
were sealed with 50% glucose solution containing
500 U/mL of heparin and 10,000 U/mL of streptokinase
and fixed. After instrumentation, 5 mL saline and 10 lL
analgesic (Temgesic) were given subcutaneously. After
recovery from anesthesia, the rats were returned to the
animal units and housed individually.
Renal clearance of 51Cr-EDTA was measured using
a constant infusion technique. Briefly, the rats were
anesthetized as described above, and then placed on
a heating table to maintain the rectal temperature at
37◦C. Through a midline incision, both ureters were ex-
posed and catheterized using a flexible plastic tubing
(0.76 plastic tubing; TYGON, Weyerhaeuser, Cleve-
land, OH, USA) as a catheter with the tip placed in
the renal pelvis for direct urine collection. The incision
was closed in order to prevent the loss of body fluid. A
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priming dose of 51Cr-EDTA (0.2 MBq) was given in-
travenously during 15 minutes followed by a sustained
infusion (0.005 MBq/min) during a 75-minute equili-
bration period and two 1-hour urine collection periods.
An intravenous infusion of 25 mmol/L glucose solution
(40 lL/min) was provided simultaneously in order to keep
an adequate minimum urine flow rate necessary for the
analysis. Timed blood samples (150 lL) were taken from
the arterial catheter every hour during the urine collec-
tion periods and replaced immediately with same volume
of heparinized donor blood. Timed urine samples were
gravimetrically collected every hour from both ureters.
The plasma and urine samples were diluted, and 51Cr-
EDTA was counted in an Auto-Gamma Counting Sys-
tem (COBRATM; Packard Instrument Company, Meri-
den, CT).
The osmolality of urine and plasma was determined
by freezing point depression (The Advanced Osmome-
ter, Model 3900; Advanced Instruments, Norwood, MA,
USA, and Osmomat 030-D, Gonotec, Berlin, Germany).
Plasma concentrations of sodium, potassium, creatinine,
and urea, and urinary concentration of creatinine and
urea were determined (Vitros 950; Johnson & John-
son, Rochester, NY, USA). The concentrations of uri-
nary sodium and potassium were determined by standard
flame photometry (Eppendorf FCM6341).
Primary antibodies
For semiquantitative immunoblotting and immuno-
histochemistry, we used previously characterized mono-
clonal and polyclonal antibodies, summarized as follows:
(1) b-actin (Sigma, A-2066); (2) AQP2 (LL127 serum,
1:3000): immune serum to AQP2 has previously been de-
scribed [25]; (3) AQP3 (LL178, 1:300): an affinity-purified
rabbit polyclonal antibody to AQP3 has previously been
described [18]; (4) AQP1 (LL266 serum, 1:3000): immune
serum to AQP1 has previously been described [26]; (5)
NHE3 (LL546, 1:300): an affinity-purified polyclonal an-
tibody to NHE3 was previously characterized [27]; (6)
Na-K-ATPase (1:5000): a monoclonal antibody against
the a1-subunit of Na-K-ATPase was previously charac-
terized [6]; (7) BSC-1 (LL320, 1:300): an affinity-purified
polyclonal antibody to the apical Na-K-2Cl cotransporter
of the thick ascending limb (TAL) has previously been
characterized [28].
Membrane fractionation for immunoblotting
On the day of the analysis, the kidneys were minced
finely and homogenized in 9 mL dissecting buffer
(0.3 mol/L sucrose, 25 mmol/L imidazole, 1 mmol/L
EDTA, pH 7.2, containing protease inhibitors: 8.5 lmol/L
leupeptin and 1 mmol/L phenylmethylsulfonyl fluoride)
with five strokes of a motor-driven Potter-Elvehjem ho-
mogenizer at 1250 rpm. This homogenate was centrifuged
in a Universal 30RF centrifuge (Hettich, Tuttlingen,
Germany) at 4000g for 15 minutes at 4◦C. Gel samples (in
Laemmli sample buffer containing 2% SDS) were made
from the supernatant.
Electrophoresis and immunoblotting
Samples of membrane fractions from whole kidney
were run on 9% or 12% polyacrylamide minigels (Bio-
Rad Mini Protean II; Bio-Rad). For each gel, an identical
gel was run in parallel and subjected to Coomassie stain-
ing [26]. The Coomassie-stained gel was used to ascer-
tain identical loading, or to allow for potential correction
for minor differences in loading after scanning and den-
sitometry of major bands. The other gel was subjected
to blotting. After transfer by electroelution to nitrocel-
lulose membranes, blots were blocked with 5% milk in
80 mmol/L Na2HPO4, 20 mmol/L NaH2PO4, 100 mmol/L
NaCl, and 0.1% Tween 20, pH 7.5 (PBS-T) for 1 hour, and
incubated with the primary antibodies overnight at 4◦C.
After being washed as above, the blots were incubated
with horseradish peroxidase–conjugated secondary anti-
body (P448, diluted 1:3000; Dako, Glostrup, Denmark).
After a final wash as above, antibody binding was vi-
sualized using the enhanced chemiluminescence (ECL)
system (Amersham International, Buckinghamshire,
UK). Controls were made with the exchange of primary
antibody to antibody preabsorbed with immunizing pep-
tide (100 ng/40 ng IgG) or with preimmune serum (diluted
1:1000). All controls were without labeling.
Semiquantitation of AQPs and sodium transporters
ECL films were scanned using a Fluor-S Multi Imager
(Bio-Rad Laboratories, Hercules, CA, USA) and Adobe
Photoshop software (San Jose, CA, USA). The labeling
density was determined of blots where samples of the
obstructed and nonobstructed kidneys from either 12 or
24 weeks of PUUO groups were run. The labeling den-
sity was corrected by densitometry of Coomassie brilliant
blue-stained gels (i.e., to control for minor difference in
protein loading).
Immunohistochemistry
Kidneys from PUUO-12W and PUUO-24W rats were
immersion-fixed by formalin. For immunoperoxidase mi-
croscopy, kidney blocks were dehydrated and embedded
in paraffin. The paraffin-embedded tissues were cut at
2 lm on a rotary microtome (Leica, Wetzlar, Germany).
The sections were deparafinated and rehydrated. For im-
munoperoxidase labeling, endogenous peroxidase was
blocked by 0.5% H2O2 in absolute methanol for 10 min-
utes at room temperature. To reveal antigens, sections
were put in 1 mmol/L Tris solution (pH 9.0) supplemented
with 0.5 mmol/L EGTA (3.6-di-oxa-octa-methylen-
di-nitrilo-tetra-acetic-acid), and were heated using a
microwave oven for 10 minutes. Nonspecific binding
of immunoglobulin was prevented by incubating the
sections in 50 mmol/L NH4Cl for 30 minutes, fol-
lowed by blocking in PBS supplemented with 1% BSA,
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Fig. 1. Changes in GFR. (A) GFR of the obstructed kidney was de-
creased to 43% of GFR in sham-operated controls after 12 weeks of
PUUO. Total GFR was decreased. (B) At 24 weeks after onset of
PUUO, GFR was decreased to 31% of GFR in sham-operated con-
trols. Total GFR was decreased. Black bars show changes in PUUO
group, and white bars show changes in SHAM group. ∗P < 0.05.
0.05% saponin, and 0.2% gelatine. Sections were incu-
bated overnight at 4◦C with primary antibody (BSC-1)
diluted in PBS supplemented with 0.1% BSA and
0.3% Triton X-100. After rinsing with PBS supple-
mented with 0.1% BSA, 0.05% saponin, and 0.2% gela-
tine for 3 × 10 minutes, the sections were incubated
in horseradish peroxidase–conjugated immunoglobu-
lin. For immunoperoxidase labeling, the sections were
washed and followed by incubation in horseradish
peroxidase–conjugated immunoglobulin (P448, 1:200;
Dako A/S, Glostrup, Denmark) diluted in PBS supple-
mented with 0.1% BSA and 0.3% Triton X-100, followed
by incubation with diaminobenzidine. The microscopy
was carried out using a Leica DMRE light microscope.
Calculations and statistics
GFR was estimated by calculating the renal clearance
of 51Cr-EDTA (CEDTA) using the following formula:
CEDTA = [U/P]EDTA × (Vu/bw)
where [U/P]EDTA denotes the urine-to-plasma count ra-
tio of 51Cr-EDTA, and (Vu/bw) is the rate of urine flow
divided by the body weight. The plasma counts corre-
spond to the midpoint of each urine collection period.
Filtered load of sodium (FLNa) was calculated by using
the following formula:
FLNa = GFR × PNa
where PNa denotes plasma sodium.
Excretion rate of sodium (UNaV) was calculated by
using the following formula:
UNaV = UNa × (Vu/bw)
where UNa denotes sodium concentration in urine.
Fractional excretion of sodium (FENa) was calculated
by using the following formula:
FENa = [U/P]Na × [P/U]EDTA
where [U/P]Na denotes the urine-to-plasma concentra-
tion ratio of sodium, and [P/U]EDTA denotes the plasma-
to-urine count ratio of 51Cr-EDTA.
Solute-free water reabsorption (TCH2O) was calcu-
lated by using the following formula:
TCH2O = [(Uosmolality/Posmolality) − 1] × (Vu/bw)
in which Uosmolality/Posmolality denotes the urine to
plasma ratio of osmolality.
All values are presented as means ± SEM. Unpaired
and paired Student t tests were used for the comparisons.
P values less than 0.05 were considered to be statistically
significant.
RESULTS
Neonatal PUUO is associated with a progressive
reduction in GFR
Glomerular filtration rate was impaired on the ob-
structed side. After 12 weeks, GFR had decreased to
43% of sham levels (115 ± 28 vs. 267 ± 36 lL/min/100g
bw, P < 0.05) (Fig. 1A). To further examine the long-
term effect of PUUO on renal function, rats were fol-
lowed to 24 weeks of age, where measurement of renal
function demonstrated a persistent and progressive GFR
reduction to 31% of sham levels (106 ± 24 vs. 343 ±
41 lL/min/100g bw, P < 0.05) (Fig. 1B). In the nonob-
structed kidney, GFR did not show compensatory in-
crease either at 12 or at 24 weeks after onset of PUUO.
Thus, total GFR in the PUUO animals were reduced
compared with sham-operated control animals at both
12 weeks (418 ± 75 vs. 555 ± 53 lL/min/100g bw, P <
0.05) and at 24 weeks (403 ± 50 vs. 679 ± 67 lL/min/100g
bw, P < 0.05).
PUUO is associated with sodium loss and impaired
urinary concentration of the obstructed kidney
To examine the effects of PUUO on renal han-
dling of sodium and the urinary concentrating mecha-
nisms, urinary sodium excretion was measured from both
the obstructed and the nonobstructed kidney. Impor-
tantly, plasma sodium levels were identical in all groups
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Table 1. Changes in renal function and plasma electrolyte values at 12 and 24 weeks after onset of obstruction
12 weeks 24 weeks
PUUO SHAM PUUO SHAM
Number 8c 6 6 7
Body weight g 353 ± 10 343 ± 33 433 ± 13 413 ± 16
Total GFR lL/min/100g bw 418 ± 75a 555 ± 53 403 ± 50a 679 ± 67
PNa lmol/mL 131.6 ± 1.1 130.3 ± 1.8 134.6 ± 1.8 140.0 ± 2.9
PK lmol/mL 4.8 ± 0.4 4.4 ± 0.2 5.0 ± 0.3 4.9 ± 0.2
PCr lmol/mL 58 ± 5 47 ± 3 59 ± 6 53 ± 6
PUrea lmol/mL 9.6 ± 0.6 7.3 ± 0.8 10.7 ± 0.7 10.0 ± 0.6
POsm mOsmol/kgH2O 295.9 ± 2.3 292.2 ± 2.3 293.2 ± 2.7 285.2 ± 13.5
FLNa lmol/min/100g bw
OBS 10.6 ± 4.7a 35.0 ± 4.9 17.0 ± 2.5a 48.3 ± 6.2
Non-OBS 39.9 ± 11.4 37.6 ± 3.0 41.7 ± 5.2 47.2 ± 4.6
Uvol lmol/min/100g bw
OBS 2.28 ± 0.67 1.63 ± 0.57 1.78 ± 0.29a,b 4.37 ± 0.83
Non-OBS 2.17 ± 0.70 2.09 ± 0.75 3.08 ± 0.50 4.69 ± 1.05
UNa lmol/mL
OBS 78.2 ± 11.7a,b 29.6 ± 5.1 92.1 ± 11.4a,b 15.2 ± 2.2
Non-OBS 37.6 ± 10.6 27.0 ± 3.4 22.9 ± 5.8 13.5 ± 1.6
UOsm mOsmol/kgH2O
OBS 403 ± 39a 809 ± 196 416 ± 52a 601 ± 124
Non-OBS 662 ± 128 907 ± 235 899 ± 175 631 ± 93
UNa V lmol/min/100g bw
OBS 0.13 ± 0.03a 0.04 ± 0.01 0.15 ± 0.02a 0.06 ± 0.01
Non-OBS 0.06 ± 0.02 0.05 ± 0.02 0.07 ± 0.01 0.06 ± 0.01
FENa %
OBS 1.20 ± 0.25a 0.14 ± 0.04 0.97 ± 0.14a 0.11 ± 0.02
Non-OBS 0.19 ± 0.09 0.15 ± 0.05 0.18 ± 0.04 0.12 ± 0.02
TCH2O lmol/min/100g bw
OBS 0.61 ± 0.42a 1.97 ± 0.63 0.42 ± 0.04a 1.56 ± 0. 39
Non-OBS 1.48 ± 0.46 2.07 ± 0. 78 3.13 ± 0.66 1.91 ± 0.31
Abbreviations are: PUUO, partial unilateral ureteral obstruction; OBS, obstructed kidney; Non-OBS, non-obstructed kidney; Total GFR, glomerular filtration rate
measured by clearance of 51Cr-EDTA; PNa, plasma sodium; PK, plasma potassium; PCr, plasma creatinine; PUrea, plasma urea; POsm, plasma osmolality; FLNa, filtered
load of sodium; Uvol, urine volume; UNa, urine sodium; UOsm, urine osmolality; UNa V, excretion rate of sodium; FENa, fractional excretion of sodium; TCH2O, solute-free
water reabsorption; bw, body weight. Mean values ± SEM are shown.
aP < 0.05 vs. SHAM group.
bP < 0.05 vs. Non-OBS. There is no significant different between 12 and 24 weeks group.
cIn 3 rats plasma electrolyte determination failed.
(Table 1). Consistent with the reduced GFR in the ob-
structed kidney, the filtered load of sodium was sig-
nificantly decreased in the obstructed kidney both at
12 weeks (10.6 ± 4.7 vs. 35.0 ± 4.9 lmol/min/100g bw,
P < 0.05) and at 24 weeks (17.0 ± 2.5 vs. 48.3 ± 6.2 lmol/
min/100g bw, P <0.05) after onset of obstruction, whereas
no changes were found in the nonobstructed kidney com-
pared with the sham-operated controls. There was a sig-
nificant increase in urinary sodium excretion at 12 weeks
(0.13 ± 0.03 vs. 0.04 ± 0.01 lmol/min/100g bw, P < 0.05),
which persisted 24 weeks after onset of PUUO (0.15 ±
0.02 vs. 0.06 ± 0.01 lmol/min/100g bw, P < 0.05). Like-
wise, the fractional excretion of sodium was increased at
12 weeks (1.20 ± 0.25 vs. 0.14 ± 0.04%, P < 0.05) and at
24 weeks (0.97 ± 0.14 vs. 0.11± 0.02%, P < 0.05). There
was no compensatory change in the sodium excretion rate
and the fractional excretion of sodium from the nonob-
structed kidney.
To examine renal handling of water, the solute-free
water reabsorption was measured. The solute-free wa-
ter reabsorption of the obstructed kidney was markedly
reduced at 12 weeks compared with the sham-operated
controls (0.61 ± 0.42 vs. 1.97 ± 0.63 lL/min/100g bw, P <
0.05), and remained decreased after 24 weeks of PUUO
(0.42 ± 0.04 vs. 1.56 ± 0.39 lL/min/100g bw, P < 0.05).
Solute-free water reabsorption did not increase in the
nonobstructed kidney either at 12 or at 24 weeks of
PUUO.
PUUO is associated with altered expression
of BSC-1 and Na-K-ATPase
There were no significant changes in the abundance
of b-actin, and no demonstrable changes in the general
abundance of proteins seen on a Coomassie blue–stained
gel between nonobstructed and obstructed kidneys from
rats subjected to both 12 and 24 weeks of neonatally in-
duced PUUO (Fig. 2A and B). The expression of major
sodium transporters (NHE3, BSC-1) and Na-K-ATPase
of the whole kidney was examined. NHE3 is expressed in
the renal proximal tubules and the TAL, and is involved
in sodium and bicarbonate reabsorption. Immunoblot-
ting revealed that the abundance of NHE3 did not differ
between the obstructed and the nonobstructed kidney in
response to either 12 or 24 weeks of PUUO (Figs. 3A and
4A). However, BSC-1, another key sodium transporter
responsible for the secondary active transport of NaCl
in the mTAL, was significantly lower in the obstructed
kidney compared with the nonobstructed kidneys in
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Fig. 2. Commassie-stained 12% polyacrylamide minigels and im-
munoblot of membrane fractions of total kidneys from rats with PUUO
for 12 (A) and 24 (B) weeks (12w PUUO and 24w PUUO; N=6, each
group). Immunoblot was reacted with anti-b-actin antibody. There was
no significant difference in the protein abundance of total kidney b-actin
between the obstructed and nonobstructed kidneys from rats subjected
to both 12 and 24 weeks of neonatally induced PUUO.
response to either 12 weeks (42 ± 10% vs. 100 ± 7%,
P < 0.05) (Fig. 3F) or 24 weeks (50 ± 10% vs. 100 ±
14%, P < 0.05) (Fig. 4F) of PUUO. Immunohistochem-
istry showed that labeling of BSC-1 in the TAL cells of
the obstructed kidney was markedly decreased (Figs. 5C,
D, G, and H) compared with that in the nonobstructed
kidney in rats with PUUO for 12 weeks (Fig. 5A and B)
and 24 weeks (Fig. 5E and F).
After 12 weeks of PUUO, Na-K-ATPase levels in the
obstructed kidney did not differ from that in the nonob-
structed kidney (Fig. 3D). However, Na-K-ATPase lev-
els decreased moderately to 79 ± 6% of the levels of
the nonobstructed kidney as examined at 24 weeks af-
ter onset of PUUO (P < 0.05) (Fig. 4D). Consistent with
this, immunohistochemistry demonstrated lack of major
down-regulation of Na,K-ATPase (data not shown).
PUUO reduces AQP2 expression
Immunoblotting using membrane fractions prepared
from the obstructed and the nonobstructed kidneys re-
vealed that PUUO for both 12 and 24 weeks was asso-
ciated with a marked down-regulation of AQP2 expres-
sion in the obstructed kidney (Figs. 6C and 7C). Both
AQP2 bands (the 29-kD and 35- to 50-kD bands) were
decreased proportionately. Densitometry of these bands
(combined) revealed a decrease in AQP2 expression af-
ter 12 weeks of PUUO to 68 ± 5% of the levels of the
nonobstructed kidney (P < 0.05) (Fig. 6D). This down-
regulation persisted at 24 weeks after onset of PUUO
(69 ± 13 vs. 100 ± 7%, P < 0.05) (Fig. 7D). Consistent with
the impaired water reabsorption, this result indicates that
neonatally induced PUUO caused a substantial and per-
sistent reduction in AQP2 protein levels of the obstructed
kidney. Consistent with the moderate down-regulation of
AQP2, immunohistochemistry demonstrated lack of ma-
jor down-regulation of AQP2 and lack of major changes
in the subcellular localization of AQP2 (data not shown).
To examine whether other aquaporins were involved
in the impaired water handling in the neonatally induced
PUUO, the expression of AQP3 and AQP1 were ex-
amined. Immunoblotting using whole kidney membrane
fractions revealed an unchanged abundance of these 2
aquaporins (Figs. 6A and E, and 7A and E).
DISCUSSION
The main results of the present study demonstrated
that neonatal PUUO in rats caused a significant decrease
in GFR of the obstructed kidney both at 12 and 24 weeks
after onset of PUUO. Moreover, PUUO was associ-
ated with reduced abundance of Na-K-ATPase, BSC-
1, and AQP2 in the obstructed kidney. Immunohisto-
chemistry confirmed down-regulaton of BSC-1 in the
obstructed kidneys. Consistent with this, sodium excre-
tion was increased and solute-free water reabsorption
decreased from the obstructed kidney. These results sup-
port our previous findings that both sodium transporters
and aquaporins are down-regulated in response to ob-
struction, and indicate that these transporters play a cru-
cial role for the persistent reduction in renal handling
of sodium and water in response to neonatally induced
PUUO.
PUUO is associated with a persistent GFR reduction
Neonatally induced ureteral obstruction results in se-
vere injury of the obstructed kidney. Consistent with this,
the results of the present study demonstrated that PUUO
induced within 48 hours of life was associated with a
marked GFR reduction both at 12 and 24 weeks after
onset of obstruction. Although total GFR was reduced,
the rats were not azotemic. Moreover, the systemic
solute balance was unchanged. This finding is consistent
with previous results demonstrating a similar reduction
in SKGFR of the obstructed kidney from guinea pigs,
which also was associated with an arrested growth of
the obstructed kidney after 3 weeks of age [29]. Using
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a slightly different model with unilateral occlusion at day
1 of birth followed by removal of the obstruction after
5 days, Chevalier et al [30] demonstrated that the ob-
structed kidney is characterized by an 80% SKGFR re-
duction together with progressive glomerular sclerosis,
tubular atrophy, and interstitial fibrosis when studied 1
year later. Both active vasoconstrictor agents [2] and a
reduction in the total number of glomeruli [30] have been
demonstrated to be involved in the GFR reduction. The
results of the present study support the view that neona-
tally induced obstruction causes long-term and progres-
sive reductions in renal function that may be paralleled
with morphologic changes of the obstructed kidney [30,
31]. Importantly, the results of the present study demon-
strate that the severity of the partial obstruction is cru-
cial for the renal functional impairment. By the modified
Ulm and Miller technique we induced a much more se-
vere obstruction that explains the persistent reductions
in SKGFR on the obstructed kidney, which is in contrast
with previous studies examining the long-term effects of
partial obstruction in young rats [32] and neonatal rats
[33]. Importantly, the growth of the animals was the same
in the PUUO rats as in the sham-operated rats, similar to
what has been demonstrated previously using the same
model [24].
Neonatal PUUO is associated with an increased
sodium excretion and a reduced abundance
of key sodium transporters
The urinary concentrating capacity is critically depen-
dent on the hypertonic medullary interstitium, which is
generated by active NaCl reabsorption as a consequence
of countercurrent multiplication and the osmotic equili-
bration of water across the tubular epithelium via aqua-
porins [34]. The active transport of sodium occurs mainly
via the key sodium transporters, which are the apical
bumetanide-sensitive Na-K-2Cl cotransporter (BSC-1 or
NKCC2) [4], the basolateral Na-K-ATPase [6], and the
type 3 Na/H exchanger (NHE3) [5].
The present study demonstrated that PUUO markedly
reduced the abundance of BSC-1 in the obstructed kid-
ney following both 12 and 24 weeks of PUUO by
immunoblotting and immunhistochemistry. Importantly,
this down-regulation of BSC-1 was associated with an
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 3. Immunoblot of membrane fractions of total kidneys from
PUUO for 12 weeks (N = 6). (A, C, E) Immunoblot was reacted with
anti-NHE3, anti-Na-K-ATPase, and anti-BSC-1 antibody. (B) Densito-
metric analysis revealed no significant difference in total kidney NHE3
expression between the obstructed and nonobstructed kidneys (132 ±
9 vs. 100 ± 10%, P > 0.05). (D) Total kidney Na-K-ATPase expression
of the obstructed kidney did not differ from that of the nonobstructed
kidney (88 ± 5 vs. 100 ± 3%, P > 0.05). (F) Total kidney BSC-1 expres-
sion in the obstructed kidney was significantly lower than that in the
nonobstructed kidney (42 ± 10 vs. 100 ± 7%, P < 0.05).
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increased urinary excretion of sodium from the ob-
structed kidney. This is consistent with our previous find-
ing in rats with UUO, where we demonstrated down-
regulation of BSC-1 and increased sodium excretion from
the obstructed kidney in response to 24 hours of UUO [9].
BSC-1 mediates sodium transport across the apical mem-
brane of the mTAL [4]. The results of the present study
therefore demonstrate that down-regulation of BSC-1
may play a major role for the renal handling of sodium in
this model of long-term PUUO. In addition, PUUO re-
duced the abundance of Na-K-ATPase after 24 weeks of
partial obstruction. In a previous study, reduction of Na-
K-ATPase abundance was also found in rats subjected to
24 hours of UUO [9]. The demonstration of a reduced
abundance of Na-K-ATPase in response to partial neona-
tal ureteral obstruction indicates that reduced Na-K-
ATPase is involved in the long-term impairment of
sodium handling in obstructive nephropathy. This find-
ing is consistent with previous studies demonstrating a
reduced activity and amount of Na-K-ATPase from the
mTAL and the IMCD of rabbit kidneys with 24 hours of
UUO [7, 8]. Thus, the results of the present study demon-
strated that long-term PUUO reduces the abundance
of both BSC-1 and Na-K-ATPase. The long-term effect
is a chronic decrease in sodium entry into the mTAL
cells. This finding supports the view that the reduction in
sodium entry caused by reduced abundance of the apical
BSC-1 and the reduced delivery of sodium to the mTAL
in the obstructed kidney as a result of a reduced FLNa may
contribute to the reduced abundance of Na-K-ATPase in
the basolateral membrane [8].
NHE3 is expressed at the apical plasma membrane
of the proximal tubule and the TAL, and it is the
predominant transporter for active secretion of H+ and
reabsorption of Na+ and HCO3− [5]. It has been demon-
strated that down-regulation of NHE3 is associated with
proximal tubule defects in sodium reabsorption, and in-
creased renal sodium excretion in several conditions [35].
Recently, we demonstrated that acute UUO was associ-
ated with a reduced abundance of NHE3 in parallel with
natriuresis [9]. However, NHE3 abundance of the ob-
structed kidney was maintained in this study. This finding
may indicate that PUUO does not directly affect trans-
porters located at the proximal tubule of the nephron.
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 4. Immunoblot of membrane fractions of total kidneys from
PUUO for 24 weeks (N = 6). (A, C, E) Immunoblot was reacted with
anti-NHE3, anti-Na-K-ATPase, and anti-BSC-1 antibody. (B) Densito-
metric analysis revealed no significant difference in total kidney NHE3
expression between the obstructed and nonobstructed kidneys (96 ±
10 vs. 100 ± 13%, P > 0.05). (D) Total kidney Na-K-ATPase expres-
sion of the obstructed kidney was significantly lower than that of the
nonobstructed kidney (79 ± 6 vs. 100 ± 5%, P < 0.05). (F) Total kidney
BSC-1 expression in the obstructed kidney was significantly lower than
that in the nonobstructed kidney (50 ± 10 vs. 100 ± 14%, P < 0.05).
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Fig. 5. Immunohistochemical analyses of BSC-1 in the TAL cells in obstructed and nonobstructed kidneys from rats with PUUO for 12 and 24
weeks. (A, B, E, F) Abundant BSC-1 labeling is seen of apical plasma membrane domains of TAL cells in the cortex (A and E) and the inner stripe
of outer medulla (ISOM) (B and F) from the nonobstructed kidney in rats with PUUO for 12 weeks (A and B) and 24 week (E and F). (C, D, G,
H) In the obstructed kidney of rats with PUUO for 12 and 24 weeks, labeling of BSC-1 in the TAL cells in the cortex (C and G) and the ISOM (D
and H) is weaker compared with nonobstructed kidneys. 12w PUUO: PUUO for 12 weeks; 24w PUUO: PUUO for 24 weeks. Magnification ×250.
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Alternatively, the finding may indicate a compensatory
phenomenon in response to prolonged PUUO.
Neonatal PUUO is associated with a reduced abundance
of AQP2 in the obstructed kidney, but maintenance of
AQP3 and AQP1 abundance
In the present study, we demonstrated that the abun-
dance of AQP2 is persistently reduced in the obstructed
kidney. Furthermore, the present study showed that
solute-free water reabsorption was reduced simultane-
ously with the reduced AQP2 abundance, demonstrat-
ing a functional association between the expression of
AQP2 and the ability to reabsorb water at the collecting
duct. Thus, these findings are consistent with an important
role of reduced AQP2 expression in the impairment of
urinary concentration and support the results from a pre-
vious study in adult rats with acute UUO, which demon-
strated that both AQP2 protein and mRNA levels were
reduced in the obstructed kidney [11]. Similar to the pre-
vious study [11], the parallel changes in AQP2 expression
and solute-free water reabsorption supports the view that
AQP2 levels are closely correlated with defects in wa-
ter reabsorption in the collecting ducts in the obstructed
kidney.
To address whether the defect in renal water handling
is due to dysregulation of other aquaporins, the abun-
dance of the proximal nephron water channel AQP1
and another collecting duct water channel, AQP3, was
examined. The results demonstrated that AQP1 abun-
dance was unchanged both at 12 and 24 weeks after on-
set of PUUO. Previously, we demonstrated that 24 hours
of BUO caused a dramatic down-regulation of AQP1,
which persisted up to at least 4 weeks after release of
BUO [12]. The present results indicate that PUUO does
not affect the abundance of the proximal tubule trans-
porters to the same proportion. Alternatively, PUUO
may induce a temporary down-regulation in AQP1, which
is not detectable at 12 and 24 weeks after onset of
PUUO. Previously, we demonstrated that BUO was asso-
ciated with dysregulation of AQP3, which persisted up to
2 weeks after release of obstruction [12]. The results of
the present study demonstrated that AQP3 abundance
was unchanged at 12 and 24 weeks after onset of PUUO.
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 6. Immunoblot of membrane fractions of total kidneys from
PUUO for 12 weeks (N = 6). (A, C, E) Immunoblot was reacted with
anti-AQP1, anti-AQP2, and anti-AQP3 antibody. (B) Densitometric
analysis revealed no significant difference in total kidney AQP1 ex-
pression between the obstructed and nonobstructed kidneys (89 ± 7
vs. 100 ± 9%, P > 0.05). (D) Total kidney AQP2 expression of the ob-
structed kidney was significantly lower than that in the nonobstructed
kidney (68 ± 5 vs. 100 ± 5%, P < 0.05). (F) There was no significant
difference in total kidney AQP3 expression between the obstructed and
nonobstructed kidneys (127 ± 20 vs. 100 ± 17%, P > 0.05).
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Mechanisms involved in reduced abundance
of BSC-1, Na-K-ATPase, and AQP2 in response
to neonatal ureteral obstruction
By using a model with UUO there are no major changes
in plasma solute concentrations because the contralat-
eral intact kidney in part compensates for the loss of
function in the obstructed kidney. Thus, it is possible in
this model to distinguish between the roles of local in-
trarenal factors and the role of systemic factors. Indeed,
the persistent reduction in BSC-1, Na-K-ATPase, and
AQP2 abundance indicates that local factors may play
a key role. Both BSC-1 and AQP2 are specifically reg-
ulated via the vasopressin/cAMP pathway [28], and it is
well accepted that urinary tract obstruction is associated
with a vasopressin-resistant urinary concentrating defect
[36]. Another study using isolated collecting ducts from
rabbits subjected to 4 hours of UUO revealed a marked
impairment in the ability of the tubule to increase water
permeability in response to both vasopressin and cyclic
AMP [37]. Thus, the present study supports the view
from previous studies that an impaired response to vaso-
pressin may be a key factor for the long-term decreased
abundance of BSC-1 and AQP2 in response to PUUO.
Urinary tract obstruction also significantly increases the
renal medullary PGE2 content [38, 39], and it is well
known that PGE2 stimulates natriuresis in the mTAL.
Importantly, it was demonstrated that blockade of PGE2
synthesis using indomethacin restores the collecting duct
water permeability in the obstructed kidney [40], suggest-
ing that an enhanced PGE2 generation in the obstructed
kidney may participate in the down-regulation of BSC-1,
Na-K-ATPase, and AQP2 demonstrated in the present
study.
It is well established that congenital ureteral obstruc-
tion is associated with development of a pronounced
interstitial inflammatory response, which subsequently
leads to progressive renal interstitial fibrosis [41]. Thus,
it is likely that the inflammatory response in the ob-
structed kidney may activate mechanisms in the tubular
cells, which interferes with the regulation of expression of
epithelial transporters and channels. Importantly, it has
been demonstrated that TGF-b1, which is a cytokine that
stimulates fibrosis and apoptosis, is expressed in tubular
epithelial cells [42]. Recently, it was demonstrated that
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 7. Immunoblot of membrane fractions of total kidneys from
PUUO for 24 weeks (N = 6). (A, C, E) Immunoblot was reacted with
anti-AQP1, anti-AQP2, and anti-AQP3 antibody. (B) Densitometric
analysis revealed no significant difference in total kidney AQP1 expres-
sion between the obstructed and nonobstructed kidneys (71 ± 5 vs. 100
± 12%, P > 0.05). (D) Total kidney AQP2 expression of the obstructed
kidney was significantly lower than that of the nonobstructed kidney
(69 ± 13 vs. 100 ± 7%, P < 0.05). (F) Total kidney AQP3 expression
of the obstructed kidney did not differ from that of the nonobstructed
kidneys (123 ± 19 vs. 100 ± 29%, P > 0.05).
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persistent UUO in the neonatal rat increases TGF-b1
expression linearly with age during the first month of
life, suggesting that an increased expression of this cy-
tokine during obstruction may have detrimental effects
on renal function. Furthermore, previous studies demon-
strated that neonatally, obstruction induces phenotypic
transformation of renal tubular cells, which may be asso-
ciated with loss of normal epithelial cell polarity [abstract;
Yoo KH et al, J Am Soc Nephrol 7:1768, 1996].
The potential mechanisms responsible for dysregula-
tion of the renal sodium transporters and aquaporins may
show a dynamic change with time. Thus, the observed
changes at 12 and 24 weeks after onset of obstruction
may not reveal the immediate response to PUUO.
Surprisingly, total GFR in the obstructed animals did
not reach the same level as GFR in the sham-operated
animals at 12 and 24 weeks after onset of obstruction due
to the lack of contralateral compensation. This indicates
that systemic factors may play an important role. It is
well know that the renal renin-angiotensin system plays a
crucial role for some of the pathophysiologic characteris-
tics observed during obstruction [1, 41], and possibly the
renin-angiotensin system may participate in a vasocon-
strictor response in the contralateral nonobstructed kid-
ney. Also, the demonstrated reduction in the contralateral
GFR may be due to long-term hyperfiltration, supporting
the view that immature kidneys are more susceptible to
glomerulosclerosis than adult kidneys [43].
The combined effects of a reduced GFR and the re-
duced abundance of sodium transporters in the mTAL
and AQP2 in the collecting duct are a reduction in the ac-
tive sodium reabsorption by the mTAL. This impairs the
generation of medullary hypertonicity and the osmotic
equilibration across the collecting duct, contributing to
the impairment of the obstructed kidney to concentrate
urine.
CONCLUSION
The present study demonstrated that major sodium
transporters and aquaporins in the obstructed kidney
are down-regulated in response to neonatally induced
PUUO. These changes were paralleled by increased
sodium excretion and a significant reduction in the
solute-free water reabsorption from the obstructed kid-
ney, demonstrating a functional association between the
molecular changes and the ability of the obstructed kid-
ney to handle sodium and water. Thus, the study indicates
that down-regulation of these transporters and channels
plays a crucial role for the persistent reduction in renal
handling of sodium and water in response to PUUO.
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